Femoral hernia pathophysiology: Difference between revisions

	Femoral hernia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Femoral hernia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Femoral hernia pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Femoral hernia pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Femoral hernia pathophysiology
CDC on Femoral hernia pathophysiology
Femoral hernia pathophysiology in the news
Blogs on Femoral hernia pathophysiology
Directions to Hospitals Treating Femoral hernia
Risk calculators and risk factors for Femoral hernia pathophysiology

Revision as of 20:54, 17 January 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Although groin hernias are much more common in men, femoral hernias occur more frequently in women.
Femoral hernias tend to carry a much higher risk of strangulation and watchful waiting is not recommended in women.
A femoral hernia protrudes below the inguinal ligament and it is medial to the femoral vessels.

[Disease name] is transmitted in [mode of genetic transmission] pattern.
Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
The development of [disease name] is the result of multiple genetic mutations.

On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

↑ Fitzgibbons RJ, Forse RA (2015). "Clinical practice. Groin hernias in adults". N. Engl. J. Med. 372 (8): 756–63. doi:10.1056/NEJMcp1404068. PMID 25693015.

@@ Line 7: / Line 7: @@
 ==Pathophysiology==
-===Pathogenesis===
+===Pathogenesis<ref name="pmid25693015">{{cite journal |vauthors=Fitzgibbons RJ, Forse RA |title=Clinical practice. Groin hernias in adults |journal=N. Engl. J. Med. |volume=372 |issue=8 |pages=756–63 |year=2015 |pmid=25693015 |doi=10.1056/NEJMcp1404068 |url=}}</ref>===
-*The exact pathogenesis of [disease name] is not fully understood.
+*Although groin hernias are much more common in men, femoral hernias occur more frequently in women.
-OR
+*Femoral hernias tend to carry a much higher risk of strangulation and watchful waiting is not recommended in women.
-*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
+*A femoral hernia protrudes below the inguinal ligament and it is medial to the femoral vessels.
-*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
-*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
-*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
-*The progression to [disease name] usually involves the [molecular pathway].
-*The pathophysiology of [disease/malignancy] depends on the histological subtype.
 ==Genetics==